Aurinia Pharmaceuticals AUPH Visp, Switzerland — Interest Expense

Similar metrics at other companies

CHE

CHESegment Vitas — Interest Expense

$50K+4.2%

CHE

CHESegment Vitas — Interest Income Expense Net

$6.24M+17.8%

AEPVIU — Interest Expense

$245M+22.5%

WLFCLeasing and  Related Operations — Interest Expense

$32.63M+1.7%

STWDInvesting and Servicing Segment — Interest Expense

$6.83M-16.1%

CNHFinancial Services — Interest Expense

$332M0.0%

Questions, answered.

What is Aurinia Pharmaceuticals's visp, switzerland — interest expense?

Aurinia Pharmaceuticals (AUPH) reported visp, switzerland — interest expense of $1M in Q1 2026.

How has Aurinia Pharmaceuticals's visp, switzerland — interest expense changed year-over-year?

Aurinia Pharmaceuticals's visp, switzerland — interest expense decreased by 9.1% year-over-year, from $1.1M to $1M.

What does visp, switzerland — interest expense mean?

Captures the interest costs incurred specifically from finance lease liabilities or related debt obligations within the Visp, Switzerland segment. This expense reflects the cost of financing the assets used in this region and impacts the segment's overall profitability. Monitoring this helps investors understand the financial burden of the company's regional leasing strategy.